TBR1
protein-codingT-box brain transcription factor 1, the group of T-box transcription factors
Gene summary
This gene is a member of a conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of numerous developmental processes. In mouse, the ortholog of this gene is expressed in the cerebral cortex, hippocampus, amygdala and olfactory bulb and is thought to play an important role in neuronal migration and axonal projection. In mouse, the C-terminal region of this protein was found to be necessary and sufficient for association with the guanylate kinase domain of calcium/calmodulin-dependent serine protein kinase. [provided by RefSeq, Dec 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0005260
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0011627
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
Variation in TBR1 was first reported in individuals in relation to autism spectrum disorder in 2014 by Deriziotis et al. (PMID: 25232744). TBR1 has also been associated with intellectual developmental disorder with autism and speech delay (OMIM #606053), 2q24 microdeletion syndrome, occipital pachygyria and polymicrogyria. Since then, phenotypes associated with variants in TBR1 have been expanded and range from autism spectrum disorder, delayed speech and language development, joint hypermobility, severe intellectual disability/global developmental delay, abnormality of the skull, cerebral palsy, etc. (Deriziotis et al., 2014 PMID: 25232744; Huang et al., 2014 PMID: 24441682; Palumbo et al., 2014 PMID:24458984).Per criteria outlined by the ClinGen Lumping and Splitting Working Group, the ID/Autism GCEP decided to lump into one disease entity, complex neurodevelopmental disorder (Mondo:0100038). There are individuals that have been reported with other phenotypes including joint hypermobility and muscle dysfunction. It is unclear at this time whether these phenotypes are related to variants in TBR1 or are due to other circumstances. Most proband information was collected from large case control studies where other phenotypic features are not reported, therefore making the phenotypic profile unclear. Twenty-six variants (missense, in-frame indel, frameshift) have been included in this curation. These variants have been reported in thirty-two individuals across two publications (PMIDs: 25232744, 32005960).More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity appears to be LOF. This gene-disease relationship is also supported by protein interactions, expression studies, animal models, and biochemical function studies (PMIDs: 25232744, 24309898, 10749215, 32005960). In summary, TBR1 is definitively associated with autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This curation was approved by the ID/Autism Gene Curation Expert Panel on 03/25/2020.
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TBR1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006593.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 29 | 3 | 33 | ||
| missense | 7 | 18 | 190 | 18 | 233 | |
| nonsense | 4 | 11 | 2 | 17 | ||
| start loss | 0 | |||||
| frameshift | 14 | 19 | 1 | 34 | ||
| splice donor/acceptor (+/-2bp) | 3 | 2 | 5 | |||
| Total | 28 | 50 | 194 | 47 | 3 | 322 |
Highest pathogenic variant AF is 0.0000015110169
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006584.1 | 6 | MANE Select | |
| Ensembl | ENSP00000374205.3 | 6 | MANE Select | |
| Ensembl | ENSP00000387023.1 | 4 | Standard | |
| Ensembl | ENSP00000387023.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- conditioned taste aversion
- brain development
- specification of animal organ identity
- amygdala development
- commitment of neuronal cell to specific neuron type in forebrain
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- protein binding
- protein kinase binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000389554
- Coding exons
- 6
- Length
- 9777
- Individuals with no LoFs
- 125456
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125457
- p
- 0.00000399
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.64 | 172 | 368 | 0.467 | 0.0000169 | 4420 |
| Missense (PolyPhen) | 66 | 167.09 | 0.39499 | 1943 | ||
| Synonymous | 0.687 | 145 | 156 | 0.930 | 0.00000745 | 1373 |
| Loss of Function | 4.39 | 1 | 24.4 | 0.0409 | 0.00000112 | 268 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable transcriptional regulator involved in developmental processes. Required for normal brain development.;
Recessive Scores
- pRec
- 0.380
Intolerance Scores
- RVIS EVS
- -0.41
- RVIS percentile EVS
- 26.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.980
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |